Treatment Study Using Frontal Intermittent Theta Burst Stimulation to Reduce Impulsivity and Suicidal Thoughts in Veterans With Mild Traumatic Brain Injury
Led by VA Office of Research and Development · Updated on 2026-04-14
55
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying a treatment for suicidal thoughts, impulsivity, and difficulties in social and work functions following a mild traumatic brain injury mTBI in Veterans. These symptoms are linked, and the study aims to see if intermittent theta burst stimulation iTBS, a high-powered magnetic pulse applied to the front of the head, can improve these conditions. The goal is to gather early data on the safety and effects of this treatment, which is approved by the FDA but not yet for these specific symptoms or location.
The trial compares active iTBS treatment to a placebo sham iTBS. The iTBS is delivered using specialized devices that stimulate the brain to promote connections between brain areas involved in impulsivity and suicidal thinking. This randomized, double-blinded study focuses on Veterans aged 22 to 65 with mTBI, impulsivity, and suicidal ideation. Treatment sessions occur over about two weeks.
Participants will be assessed before, during, and after treatment using scales measuring social and occupational functioning and suicidal thoughts. Brain imaging will be done to examine changes in brain connectivity related to treatment. The main outcomes include treatment session completion rates and changes in functioning and suicidal ideation. Safety, tolerability, and feasibility of the treatment will also be monitored throughout the study.
CONDITIONS
Brief Title
Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury
Research Team
A
Alexandra L Aaronson, MD
I
Ibuola Kale
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Active iTBS
Sham iTBS
What it is
A randomized active device delivering intermittent theta burst stimulation to the frontal pole
A matching sham version of the device procedure using the same coil but without active stimulation
Role in the trial
Investigational treatment arm receiving active iTBS
Placebo control arm receiving sham iTBS
Purpose of use
To assess whether active iTBS can reduce impulsivity and suicidal ideation in veterans with mTBI
To serve as placebo control for evaluating investigational iTBS effects
How it is administered
Delivered via Magventure MagProX100 system with switchable Cool Coil B65 A/P over the frontal pole for daily sessions
Same device setup using the coil switch in placebo mode for daily sessions
External evidence context
iTBS has shown reductions in suicidal ideation in depression in randomized studies
Sham iTBS is not expected to reduce symptoms beyond placebo effects
Important risks
Risks are not yet established; safety and tolerability are being evaluated in this pilot study
Minimal risk as sham procedure; subject to tolerability assessments
Important limitations
This is a small pilot trial in veterans with mTBI; results may not generalize to broader populations
Sham arm controls placebo but cannot capture long-term or real-world effects
Patient impact
Reductions in suicidal ideation observed in depression suggest potential benefit for urgent symptom relief
No symptom improvement beyond placebo expected
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 22Years - 65Years
All Genders
Eligibility Criteria
You may qualify if you...
Aged 22 to 65 years
Able to read and speak English
Meets criteria for mild traumatic brain injury based on the symptom attribution and classification scale
Has suicidal ideation rating greater than 1 within the past month
Has a history of impulsivity documented or scores above 20 on the negative urgency impulsivity subscale
You will not qualify if you...
Has contraindications to intermittent theta burst stimulation, such as epilepsy
Has contraindications to MRI, including claustrophobia or ferromagnetic metal implants
Has an active substance use disorder
Has a history of moderate to severe traumatic brain injury
Has a history of non-traumatic brain injury like stroke, neurosurgery, or hemorrhage
Has a history of or current psychosis not caused by an external factor
Is pregnant
Has an unstable medical condition
Had a major surgery within the past 12 weeks
Experienced traumatic brain injury within the past year
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for screening and enrollment
Implementation
Duration - Approximately 2 weeks
Participants receive intermittent theta burst stimulation (iTBS) or placebo iTBS to evaluate its effects on impulsivity and suicidal ideation.
Daily visits for iTBS sessions over 2 weeks
Follow-up
Duration - Up to 2 weeks after treatment
Participants are monitored for changes in social and occupational functioning, impulsivity, and suicidal ideation after completing the iTBS sessions.
1 to 2 visits for outcome assessments
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Evaluating Attachment Based Family Therapy to Reduce Suicidal Thoughts and Behavior in Young Adults Compared to Standard Treatment
Peer-Delivered Recovery-Focused Suicide Prevention Program for Veterans with Serious Mental Illness
Brain Stimulation Treatment Using Accelerated Intermittent Theta Burst Stimulation for Depression and Suicidal Thoughts in Adolescents and Young Adults Aged 15 to 25
Study of Low-Dose Buprenorphine Added to Usual Treatment for Reducing Severe Suicidal Thoughts in Adults with Major Depression
Evaluating Suicide Intervention Methods for Teens Aged 11 to 17 During High Risk Periods
Rapid Treatment of Suicidal Thoughts Using Intramuscular Ketamine and Psychotherapy in the Emergency Department A Randomized Clinical Trial
Study of Crisis Response Planning to Help Reduce Suicidal Thoughts in Active Duty Military Members
Evaluation of a Short Psychosocial Intervention Program ASSIP-OA to Prevent Suicide in Adults Aged 65 and Older
Auditory Training to Improve Hearing After Mild Traumatic Brain Injury for Adults Aged 18 to 55
Combining Crisis Response Planning with Massed Cognitive Processing Therapy to Reduce Suicide Risk in Military Personnel and Veterans with PTSD
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Frontal Pole Neuromodulation for Impulsivity and Suicidality in Veterans With Mild Traumatic Brain Injury and Common Co-Occurring Mental Health Conditions: Protocol for a Pilot Randomized Controlled Trial.